» Authors » Lokesh C Mishra

Lokesh C Mishra

Explore the profile of Lokesh C Mishra including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 90
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Naidu S, Pandey J, Mishra L, Chakraborty A, Roy A, Singh I, et al.
Ecotoxicol Environ Saf . 2023 Mar; 255:114783. PMID: 36963184
In the current scenario of global warming and climate change, plants face many biotic stresses, which restrain growth, development and productivity. Nanotechnology is gaining precedence over other means to deal...
2.
Sindhu R, Tiwari A, Mishra L, Husain M
Cancer Biother Radiopharm . 2012 Sep; 27(7):452-6. PMID: 22947088
The absorption and fluorescence spectra of the 7-diethylamino-4-methyl coumarin (DAMC) in ethanol-water (1:9 v/v) solution at varying pH values were investigated. The interaction between DAMC and bovine serum albumin (BSA)...
3.
Yadav N, Dixit S, Bhattacharya A, Mishra L, Sharma M, Awasthi S, et al.
Chem Biol Drug Des . 2012 Mar; 80(2):340-7. PMID: 22429524
Twenty-seven novel chalcone derivatives were synthesized using Claisen-Schmidt condensation and their antimalarial activity against asexual blood stages of Plasmodium falciparum was determined. Antiplasmodial IC(50) (half-maximal inhibitory concentration) activity of a...
4.
Mishra L, Bhattacharya A, Sharma M, Bhasin V
Am J Trop Med Hyg . 2010 Jan; 82(1):148-50. PMID: 20065012
Most malaria endemic regions are co-infested with HIV infection. Treatment of one may affect outcome of the other in co-infected individuals. HIV protease inhibitors, indinavir or nelfinavir, are important antiretroviral...
5.
Bhattacharya A, Mishra L, Sharma M, Awasthi S, Bhasin V
Eur J Med Chem . 2009 Mar; 44(9):3388-93. PMID: 19269069
Use of artemisinin based combination therapies (ACTs) is increasing in treatment of malaria. Their extensive and indiscriminate deployment will ultimately lead to selection of resistance. Thus, alternate ACTs are needed....
6.
Mishra L, Bhattacharya A, Bhasin V
Acta Trop . 2008 Dec; 109(3):194-8. PMID: 19063856
Resistance to synthetic first-line antimalarial drugs is considered to be a major cause of increased malaria morbidity and mortality. Use of artemisinin-based combination therapies (ACTs) is being encouraged to reduce...
7.
Bhattacharya A, Mishra L, Bhasin V
Am J Trop Med Hyg . 2008 May; 78(5):721-8. PMID: 18458303
Currently available artemisinin-based combination therapies (ACTs) for malaria are inadequate. There remains an enormous unmet need for alternate artemisinin-based combination therapies. One of the fastest methods to identify promising artemisinin-based...
8.
Mishra N, Arora P, Kumar B, Mishra L, Bhattacharya A, Awasthi S, et al.
Eur J Med Chem . 2007 Nov; 43(7):1530-5. PMID: 17977622
The synthesis of novel 1,3-diaryl propenone derivatives and their antimalarial activity in vitro against asexual blood stages of human malaria parasite, Plasmodium falciparum, are described. Chalcone derivatives were prepared via...
9.
Mishra L, Bhattacharya A, Bhasin V
Am J Trop Med Hyg . 2007 Mar; 76(3):497-501. PMID: 17360874
Emergence of drug-resistant Plasmodium falciparum strains to conventional first-line antimalarial drugs has compelled many countries to reorient their drug policies to adopt artemisinin-based combination therapies (ACTs) for treatment of uncomplicated...